LAPRÉVALENCE DES HÉPATITES VIRALES (B, C) SYPHILIS VIH CHEZ LES SCHIZOPHRÈNES , DE LA ET DU (A propos de 444 cas)

Somatic diseases in patients with serious psychiatric disorders are now an important issue in the overall management of these patients. Indeed, the physical health of mental patients is often overlooked, which complicates the therapeutic management and rang the vital prognosis.Viral hepatitis and STIs are the most frequents somatic comorbidity in psychiatric patients, for several reasons: mainly the lack of awareness of the disease,and poor risk estimate for this group of patients.To date, no study has been conducted on a national scale, hence the need to conduct a study in our training.
Objectives:The aim of our study was to investigate the prevalence of viral hepatitis (B, C) and STIs (syphilis, HIV) in schizophrenic patients, and to determine the risk factors for these infections in this group of patients.
Methods:We conducted a cross-sectional study of 444 patients treated for schizophrenia hospitalized in the psychiatric ward of the Ibn Al Hassan Hospital, CHU Hassan II of Fez, during the period from March 2013 to September 2013, with the help of a pre established questionnaire.Data entry and processing were made using SPSS v20 software. A varied kingdom analysis and a logistic regression were used to identify the factors of risk.
Results:The mean age of our sample was 33.51 +/- 9.213 years, with a male 89.8%; the paranoid type was most frequent with a rate of 60%. Found prevalences were 1.6% for hepatitis B, 0.9% for hepatitis C, 3.6% for syphilis and 0% for HIV.There were no significant differences in sociodemographic data in positive patients with hepatitis, the relationship between hepatitis and injection history was not significant, and for the disturbed sexual behavior (protection through use, type of partner). By cons, for syphilis, age and unprotected sex were risk factors for syphilis (p <0.05), and for the history of jaundice whose association was close to significance (p = 0.083). However, we found no significant difference in prevalence between the different clinical forms of schizophrenia. The analysis did not also objectified significant result between the positive seroprevalence for HBV, HCV and syphilis and disruption of the overall operation or at the given CGI or PANSS. Drug use in our population was reserved for non-parenteral especially cannabis. Conclusion:Schizophrenia should be included in risk groups of hepatitis and STIs, and benefit from a prevention strategy that should be included in the action plan of comprehensive care for all severe mental illness in order to improve the quality of life of these patients

Référence854
Année2015
TypeThèse
Lien document
AuteurJarnige K
DisciplinePsychiatrie
EncadrantRammouz I